·
San Diego, January 22, 2025 — SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, has published an innovative two-step Multi-Cancer Early Detection (MCED) strategy in Cancer Research Communications. The study focuses on the implementation of OncoSeek, an initial screening test utilizing seven protein tumor markers and artificial intelligence, followed by SeekInCare, a secondary genomic test for individuals who test positive in the first round. This innovative method not only minimizes the false positives but also alleviates the financial burden on healthcare systems.